Combinatorial effects of surface plasma-treating and aligning PCL/chitosan nanofibers on the behavior of stem cell-derived cardiomyocytes for cardiac tissue engineering
Surface Modification
Surface Engineering
DOI:
10.1016/j.apsusc.2024.159680
Publication Date:
2024-02-13T05:14:14Z
AUTHORS (9)
ABSTRACT
Pluripotent stem cell (PSC)-derived cardiomyocytes offer vast potential in heart failure therapy, yet their immaturity poses challenges. To solve this issue, a multifaceted approach combining exclusive biochemical/topographical cues in the design of substrates mimicking the cardiac extracellular matrix was followed. Firstly, polycaprolactone (PCL)/chitosan nanofibers were electrospun in a random and aligned fashion, thus forming myocardium-like constructs. The scaffolds were then subjected to Ar and N2 dielectric barrier discharge treatments, thus further improving their surface properties. The Ar plasma incorporated oxygen-containing functionalities onto the nanofibers surface with an additional implantation of nitrogen-containing groups upon N2 plasma treatment, which both enhanced fibers’ wettability. No topographical/dimensional damages were detected post-plasma treatments, except for a slight decrease in the surface roughness of the aligned nanofibers, which led to a decrease in their tensile stress. Both plasmas significantly enhanced the adhesion of PSC-derived cardiomyocytes that displayed more circular versus highly elongated body/nucleus morphologies on random versus aligned nanofibers, respectively. Interestingly, the cell alignment was less pronounced on GeltrexTM-coated nanofibers. Furthermore, increased sarcomere distance and organization were observed on aligned plasma-treated nanofibers, suggesting an enhanced cell maturation. Overall, PCL/chitosan nanofibers with aligned orientation and plasma-induced surface chemistry hold promise in cardiac tissue engineering applications.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (102)
CITATIONS (2)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....